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Background. Malaria infections in the first trimester of pregnancy are frequent and deleterious for both mother and child 
health. To investigate if these early infections are newly acquired or already present in the host, we assessed whether parasites de-
tected before pregnancy and those detected in early pregnancy are the same infection.
Methods. We used data from the preconceptional “RECIPAL” study (Benin, 2014–2017). Sixty-three pregnant women of 411 included 
who had a malaria infection detected by quantitative polymerase chain reaction both before pregnancy and at the first antenatal care 
(ANC) visit were selected for this study. Two highly polymorphic markers, msp-2 and glurp, and a fragment-analysis method were used to 
enumerate the Plasmodium falciparum genotypes and to quantify their proportions within isolates. An infection was considered as persis-
tent when identical msp-2 and glurp genotypes were found in the corresponding prepregnancy and early-pregnancy samples.
Results. The median time between the 2 malaria screenings was 3 months. The median gestational age at the first ANC visit was 
6.4 weeks. Most infections before pregnancy were submicroscopic infections. Based on both msp-2 and glurp genotyping, the infec-
tion was similar before and in early pregnancy in 46% (29/63) of cases.
Conclusions. Almost half of P. falciparum infections detected in the first trimester originate before pregnancy. Protecting young 
women from malaria infection before pregnancy might reduce the prevalence of malaria in early pregnancy and its related poor ma-
ternal and birth outcomes.
Keywords.  malaria; pregnancy; Africa; genotyping techniques; polymerase chain reaction.
Malaria in pregnancy is a major public health problem in 
sub-Saharan Africa, with 39 million pregnant women at risk 
of Plasmodium falciparum infection every year [1]. Malaria has 
substantial risk for pregnant women (anemia), the fetus (fetal 
growth restriction, fetal loss), and the newborn child (low birth 
weight, preterm birth), leading to an increased risk of neonatal 
and infant mortality [2, 3]. In sub-Saharan African countries, 
preventive strategies against malaria associated with pregnancy 
are based on long-lasting insecticide–treated bed nets and in-
termittent preventive treatment in pregnancy (IPTp) with 
sulfadoxine-pyrimethamine (SP) [4]. Intermittent preventive 
treatment in pregnancy consists of the administration of SP 
at each antenatal care (ANC) visit from the second trimester 
of pregnancy onwards; SP is contraindicated during the first 
trimester because of potential teratogenic effects on the fetus. 
Insecticide-treated bed nets are distributed at the first ANC 
visit, which generally occurs around 4–5 months of pregnancy. 
Therefore, pregnant women remain unprotected or insuffi-
ciently protected during the first months of pregnancy, partic-
ularly during the first trimester. However, this period of fetal 
life may be highly critical in the case of pregnancy-associated 
malaria because of the sequestration of parasites and their ac-
cumulation in the placenta simultaneously with trophoblast 
differentiation and vascular remodelling of the uterus [2]. We 
recently showed that women infected in the first trimester 
had a significantly higher risk of maternal anemia at the end 
of pregnancy compared with uninfected women at the same 
 period and that they were more likely to have low-birth-weight 
newborns when infected both in the first trimester and later in 
pregnancy [5].
Malaria is particularly frequent in the first trimester of 
pregnancy [6–8] and might cause up to 70% of the total ex-
posure to placental malaria infection [9]. With data from a 
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malaria before pregnancy were more likely to be infected with 
malaria in the first trimester of pregnancy compared with un-
infected women before pregnancy [6, 7]. Also, the proportion 
of microscopic infections was almost 2 times higher at the first 
ANC visit (6 weeks’ gestation) than before conception.
We therefore hypothesized that malarial infections in the first 
trimester of pregnancy are already present before pregnancy. 
Also, we assumed that most of these prepregnancy infections 
were submicroscopic (ie, only detectable by polymerase chain 
reaction [PCR]) and that most become patent and detectable 
with microscopy in early pregnancy. Therefore, the main objec-
tive of the present study was to investigate if parasites detected 
in women before pregnancy and those detected during the first 




In this project we used data from a previous study, RECIPAL 
(REtard de Croissance Intra-utérin et PALudisme), which was 
conducted in the south of Benin from June 2014 to August 2017 
[10]. The RECIPAL study was established to assess the effect 
of malaria in the first trimester of pregnancy on birth out-
comes and was a preconceptional longitudinal cohort study. 
A total of 1214 women of reproductive age were first recruited 
and followed monthly until becoming pregnant. At inclusion, 
they were screened for malaria using both microscopy (thick 
blood smear test [TBS]) and quantitative PCR (qPCR). After 
30  months of follow-up, 411 women became pregnant. Their 
pregnancy was identified with a mean of 6.9 weeks of gestation 
based on early ultrasound scan. Once pregnant, women were 
followed up monthly at the facility level for clinical examina-
tion and malaria screening (using both microscopy and qPCR). 
Only microscopy results were available at the time of the visit, 
and qPCR was postponed to the end of follow-up. Before preg-
nancy and from the second trimester of pregnancy onwards, 
women were treated with artemether-lumefantrine if infected 
with microscopic malaria whether or not they were sympto-
matic. In the first trimester of pregnancy, infected women were 
treated with quinine.
Inclusion Criteria for the Genotyping Study
To eliminate the risk of new infections between the first 
screening before pregnancy and subsequent screening in early 
pregnancy, we selected, among 411 pregnant women, those 
with a positive PCR (proof of existence of the parasite’s DNA) 
both before pregnancy and at the first ANC visit during preg-
nancy (shortest time between the 2 infections). All pairs of 
PCR-positive infections, whether or not detected by micros-
copy, were considered. Based on these criteria, 66 women were 
included in this study.
Microscopy and Quantitative Polymerase Chain Reaction Testing
Microscopy and qPCR testing were performed in the framework 
of RECIPAL study. Briefly, TBSs were stained with Giemsa, and 
parasitemia was quantified by the Lambaréné method [11]. 
Blood smears were considered negative if no parasites were seen 
in all 10-µL TBSs. The presence of P. falciparum was also tested 
in duplicate by a qPCR that targeted the 18S ribosomal DNA 
(rDNA) after 40 cycles of amplification [12, 13]. Starting from 
50 µL of blood spot samples on filter paper, the extraction pro-
cedure leads to a final volume of 150 µL extracted DNA. A test 
sampling of 5 µL extracted DNA thus corresponds to 1.7 µL of 
blood. All parasite densities estimated for this study were de-
termined by qPCR. Parasitemia was determined by extrapola-
tion of cycle thresholds (Ct) from a standard curve generated 
with purified DNA from 3D7 P.  falciparum-infected erythro-
cyte culture. Samples without amplification (no Ct detected) 
were considered as negative, and a density of 2 parasites/μL was 
assigned if amplification was observed out of the lower range 
of the standard curve (5 parasites/μL). Purified DNA from the 
3D7 parasite strain was used as a positive control, whereas a 
negative control with no DNA template was run in all reactions. 
Plasmodium falciparum infections detected by qPCR, but not by 
microscopy, were classified as submicroscopic.
Molecular genotyping of the Polymorphic Genes msp-2 and glurp
In this study, a fragment-analysis method was used to enumerate 
all of the P. falciparum genotypes and to quantify their propor-
tions within isolates [14]. This method is based on the poly-
morphism of the gene encoding for merozoite surface protein 
2 (MSP-2), an abundant surface component in the erythrocyte-
invading stage of P. falciparum [15]. A highly polymorphic re-
gion showing considerable variations in size and sequence has 
been described in block 3 of the msp-2 gene [16]. Women’s sam-
ples showing the same msp-2 profile on both before-pregnancy 
and early-pregnancy samples were then analyzed on the glurp 
(glutamate-rich protein) marker, which is also a highly poly-
morphic marker in P.  falciparum [17, 18]. Thus, by using 2 
highly polymorphic markers, we aimed to obtain better geno-
type identification when comparing pairs of isolates for each 
woman [17, 19, 20].
Analyses of a fluorescent qPCR block 3 of the msp-2 and glurp 
domains were conducted as described in a previous study [14]. 
This method is based on a qPCR amplification with a fluorescent 
primer, followed by capillary gel electrophoresis, processed in 
an ABI Prism 3130 XL Genetic Analyzer (Perkin Elmer Applied 
Biosystems) to enumerate and quantify fluorescent fragments, 
and therefore to discriminate alleles of different sizes in each 
isolate. The fragment-analysis method was processed in the 
sequencing platform at Bichat Hospital (Paris, France). The true 
value of this method has already been evaluated in clinical set-
tings in previous studies [19–22]. This method is simple to use, 






/cid/advance-article/doi/10.1093/cid/ciaa841/5860917 by London School of H
ygiene & Tropical M
edicine user on 21 April 2021
Preconceptional Origin of Malaria in Pregnancy • cid 2020:XX (XX XXXX) • 3
from persistent infections in in vivo studies may be more pre-
cise in comparison to other methods because the proportion of 
each genotype (previous and new) is determined in a polyclonal 
isolate. This amplification was based on the semi-nested PCR 
technique reported by Snounou et al [23]. Data obtained from 
the ABI Prism 3130 XL Genetic Analyzer were analyzed using 
GeneMapper software (version 8; Applied Biosystems). Each 
genotype was characterized by the size and the area under the 
curve of the peak corresponding to the msp-2 and glurp qPCR 
products.
Statistical Analysis
First, all the samples were genotyped for the msp-2 polymor-
phic marker. We distinguished 2 different groups of women: 
(1) women with the same infection profile before and in early 
pregnancy, and (2) women with different infections. We con-
sidered 2 infections as identical in the following cases: (1) with 
the same number of genotypes and identical genotypes (identical 
infection profile), and (2) with 1 or 2 minority genotypes (<2%) 
that appeared or disappeared between the 2 time points in each 
woman. All women who had an identical msp-2 profile infection 
on both consecutive samples were analyzed for the glurp RII re-
gion marker. An infection was considered as persistent when iden-
tical msp-2 and glurp genotypes were found in the corresponding 
prepregnancy and early-pregnancy samples. In this case, the 2 pro-
files were either completely identical for the same marker or they 
had 1 or 2 missing or additional minority genotypes.
Baseline and malaria characteristics at inclusion before 
conception and during pregnancy are presented for women 
included in RECIPAL, and those included in the present 
genotyping study. Based on both msp-2 and glurp, the number 
(proportion) of women with an identical infection before and 
in early pregnancy was calculated and was then classified ac-
cording to the type (microscopic vs submicroscopic) of infec-
tion before pregnancy.
Stata version 13 for Windows (StataCorp) was used for all 
statistical analyses.
RESULTS
Among the 66 women who met the inclusion criteria (positive 
qPCR for isolates from both before pregnancy and early preg-
nancy), 3 had no results for msp-2 genotyping (missing data).
The main characteristics of the women included in the 
RECIPAL project and of the 63 of those who were included in 
the genotyping study are presented in Table 1. Most women in-
cluded in the present study were multigravid (89%). Among the 
63 women in the current study, only 11 (17.5%) presented with 
a microscopic infection before pregnancy. The median time be-
tween the 2 malaria screenings was 96 days (interquartile range 
[IQR], 42–193  days). The median gestational age at the first 
ANC visit was 6.4 weeks (IQR, 5.1–7.1 weeks).
Results of msp-2 and glurp genotyping are presented in 
Figure  1. Based on only msp-2 genotyping, 42 of 63 women 
(66.7%) had the same infection profile before pregnancy and in 
early pregnancy. Based on both msp-2 and glurp genotyping, the 
infection was considered similar before and in early pregnancy 
in 46% (29/63) of cases (Figure 1).
Figure  2 presents different profiles of infection at 2 time 
points: before pregnancy and at the first ANC visit. Among the 
63 included women, 52 (83.0%) had a submicroscopic infec-
tion before pregnancy. Most of them (46/52; 88.5%) still had 
a submicroscopic infection in early pregnancy, with an infec-
tion profile similar to that before pregnancy for more than 
half of the women (25/46; 54.3%). The median time between 
the 2 malaria screenings was higher for the 21 women with a 
different infection profile (4  months) compared with the 25 
women with a similar infection profile (3 months) before and 
in early pregnancy. Eleven women (17%) had a microscopic in-
fection before pregnancy. The majority (7/11) presented with 
a  submicroscopic infection with a different profile of infection 
in early pregnancy. Presenting with a microscopic malaria in-
fection in early pregnancy was more likely in women with a 
microscopic infection before pregnancy (3 out of 11 women) 
compared with women with a submicroscopic infection before 
pregnancy (6 out of 52 women).
DISCUSSION
Our findings show the persistence of malaria infection from 
the preconceptional to the early-pregnancy period. We showed 
that a high proportion (46%) of PCR-positive infections de-
tected at the beginning of the first trimester of pregnancy were 
already present before pregnancy. Most of these infections were 
 submicroscopic as they were only detected by qPCR.
Following World Health Organization recommenda-
tions, insecticide-treated mosquito nets and IPTp-SP are 
currently used in all areas in Africa with moderate to high 
malaria transmission. However, the IPTp-SP treatment ex-
cludes the first trimester of pregnancy, a time frame when 
the infections are frequent and harmful to pregnant woman 
and their fetus [5, 24–26]. Previous epidemiological studies 
have shown a high prevalence of malaria infection often ob-
served at the first ANC visit in pregnant women who did not 
receive IPTp-SP [27–29]. One explanation is the low use of 
bed nets by young women in poor areas [30, 31]. Moreover, 
a high prevalence of asymptomatic (thus untreated) infec-
tions in adolescents and young women has been reported in 
several studies [7]. Another factor that may potentially con-
tribute to the high prevalence of malaria in early pregnancy is 
the selection of a pregnancy-specific parasite phenotype, spe-
cifically expressing the var2csa member of the var multigene 
family [32, 33]. Our previous findings suggest that the var-
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before pregnancy, which can be rapidly selected in vivo under 
favorable physiological conditions [8, 34]. Complementary 
phenotyping analyses are ongoing to assess whether those 
pregnancy-specific parasites in early pregnancy originate 
from a specific population of parasites before conception (T. 
Ndam, personal communication, 2020).
Berry et  al [35] previously assessed the hypothesis of ma-
laria infections persisting into pregnancy. They showed that 
as many as 41% of women at the first ANC visit were infected 
with malaria when their entire pregnancy before the first ANC 
had occurred in the dry season. Another recent study based 
on the level of VAR2CSA-specific immunoglobulin G (IgG) 
among Ghanaian women at their first ANC visit reinforces the 
notion that placental malaria often arises from parasites al-
ready present at the time of conception [36]. Finally, in Benin, 
genotyping of recurrent infections from 18 primigravid women 
infected before pregnancy led to results comparable to ours, 
namely a high proportion of infections were persistent from 
the preconceptional period [8]. The present study completes 
the first one from Benin by including multigravid women and 
by using a more sensitive genotyping approach. However, these 
results may only be generalizable to epidemiological contexts 
similar to that of South Benin.
Figure 1. Results of msp-2 (merozoïte surface protein-2) and glurp (glutamate-
rich protein) genotyping: Benin, 2014–2017.
Table 1. General and Malaria Characteristics of Women Whether or Not Included in the Genotyping Analysis: Benin, 2014–2017
Characteristics
Women Included in the Genotyping 
Study (n = 63/411)
Women Not Included in the 
Genotyping Study (n = 348/411)
General characteristics   
 Mean ± SD age, years 26.2 ± 5.3 26.9 ± 5.0
 Primigravid, n (%) 7 (11.1) 26 (7.5)
 Illiterate, n (%) 50 (79.4) 240 (69.0)
 HIV positive, n/N (%) 2/56 (3.6) 4/298 (1.3)
 Low socioeconomic level,a n (%) 25 (39.7) 115 (33.1)
At inclusion before conception   
 Anemia,b n (%) 37 (58.7) 184 (53.3)
 qPCR-positive infection, n (%) 63 (100) 53/320 (16.6)
 Parasite density,c parasites/µL 46 (25–82) 15 (8–27)
 Microscopic infection, n (%) 11 (17.5) 12/320 (3.8)
 Submicroscopic infection,d n (%) 52 (82.5) 47/53 (88.7)
During pregnancy   
 Median (IQR) time between malaria screening before/in 
early pregnancy, days
96 (42–193) 125 (57–233)
At the first ANC visit   
  Median (IQR) gestational age at the first ANC visit, weeks 6.4 (5.1–7.1) 6.4 (5.4–7.7)
  qPCR-positive infection, n (%) 63 (100) 68/317 (21.5)
  Parasite density,c parasites/µL 46 (23–91) 38 (19–79)
  Microscopic infection, n (%) 9 (14.3) 20/317 (6.3)
  Submicroscopic infection,d n (%) 54 (85.7) 58/68 (85.3)
During the entire pregnancy, n (%)   
  At least 1 microscopic infectione 34 (54.0) 106 (30.5)
  Placental malaria infection 4/36 (11.1) 11/199 (5.5)
Abbreviations: ANC, antenatal care; HIV, human immunodeficiency virus; IQR, interquartile range; qPCR, quantitative polymerase chain reaction; RECIPAL, REtard de Croissance Intra-utérin 
et PALudisme 
aSocioeconomic level was approximated using a synthetic score combining occupation and ownership of assets, which was then categorized according to tertiles within the whole RECIPAL 
cohort; a “low” socioeconomic level corresponds to the lower tertile.
bAnemia before conception defined as a hemoglobin level <12 g/dL.
cValues are geometric means (95% confidence interval); parasite density by qPCR was calculated in positive qPCR specimens.
dProportion of submicroscopic infection (ie, qPCR-positive but thick blood smear test–negative) among qPCR-positive infections; overall proportion of submicroscopic infections before con-
ception (47/320, 15.3%) and at the first ANC visit (58/317, 19.5%).
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The strength of this study is the use of 2 highly polymor-
phic markers, msp-2 and glurp, which provide a higher sen-
sitivity in the detection of P.  falciparum genotypes. Msp-1, 
circumsporozoite protein (csp), and other parasite polymor-
phic markers usually used in genotyping studies are less dis-
criminant. Based on both msp-2 and glurp genotyping, the 
percentage of women with a persistent infection dropped from 
66% (only msp-2) to 46% (msp-2 and glurp). We assume that 
the use of glurp as a highly polymorphic marker is an added 
value since it makes this genotyping method more informa-
tive. We used a fragment-analysis method to enumerate the 
P.  falciparum genotypes and to quantify their proportions 
within the isolates. The area under the curve is proportional 
to the quantity of PCR amplicons for each genotype [37]. Our 
data show that genotypes with a minor frequency in the isolate 
disappear most of the time or persist with the same ratio in the 
isolate. Furthermore, this method detects minority genotypes 
compared with classical molecular methods. This approach 
consistently identified genotypes as low as 0.5%. Comparable 
sensitivity has been obtained in studies using 32P-labeled pri-
mers or probes, which are time-consuming techniques.
In our study population, the proportion of submicroscopic 
infections compared with microscopic infections was iden-
tical in the preconceptional and very-early-pregnancy period 
(82.5%). We therefore did not show that these subpatent infec-
tions in the preconceptional period become microscopically 
detectable in early pregnancy. This was recently demonstrated 
by Tuike Ndam et al [8] in Benin, although in their study, they 
considered all malarial infections until the fourth month of 
pregnancy. Previous results based on the RECIPAL study also 
showed that the ratio between submicroscopic and microscopic 
infection started to decrease at the end of the first trimester [7]. 
Our study design is therefore not suitable for demonstrating 
such a switch towards microscopic infections since malaria was 
detected very early in pregnancy (at ~6 weeks’ gestation) when 
the development of the placenta is not complete; no sequestra-
tion and multiplication of parasites are therefore possible in 
such an environment. Another explanation of the high preva-
lence of submicroscopic infections in early pregnancy may be 
the high percentage of multigravid women in our selected study 
group (83%). The development of a specific immunity against 
the parasite during previous pregnancies must be taken into 
consideration in this case [3].
In addition, the fact that our study population mainly in-
cluded multigravida women may partly explain the apparently 
low proportion of pregnant women with persistent infection 
(29/411). Other factors probably contributed to this. Indeed, 
11 women out of 63 (17%) had a microscopic infection be-
fore pregnancy for which they were treated with artemether-
lumefantrine. In addition, women infected both before and 
during pregnancy were identified based on a single screening 
before pregnancy. Finally, the elapsed time of 3 months between 
the 2 screenings possibly increased the risk of de novo infec-
tion. Therefore, the overall proportion of women with a persis-
tent infection may be higher than that reported in the RECIPAL 
framework.
Figure 2. Profiles of infection (submicroscopic/microscopic and similar/different infection) before pregnancy and in early pregnancy. RECIPAL: Benin, 2014–2017. Bold 
arrows indicate the most frequent profiles. *Submicroscopic infections were Plasmodium falciparum infections detected by qPCR but not by microscopy. Abbreviations: qPCR, 
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There is growing evidence that, in the first trimester of 
pregnancy, Plasmodium infection greatly contributes to the 
burden of malaria in pregnancy and has major deleterious 
clinical consequences on maternal and child health [5, 24–
26]. Therefore, clearance of infection or prevention of infec-
tion during this period is likely to have a major effect both on 
the number of women with placental infections and on the 
deleterious effects of these infections [9]. In early pregnancy, 
only insecticide-treated bed nets are recommended for the 
prevention of malaria, but the coverage is very low; IPTp-SP 
is only recommended after the first trimester of pregnancy 
because of potential teratogenic effects of SP. Currently, there 
are no other appropriate and available measures that can be 
used in this critical period of pregnancy, with the knowledge 
that reaching women during this period is challenging since 
women in Africa usually do not attend the maternity clinic 
before 4 or 5 months of pregnancy.
Our data confirm that a high proportion of P. falciparum in-
fections detected in the first trimester result from the persist-
ence of the infection acquired before pregnancy. Therefore, we 
believe that targeting young women living in endemic areas 
protects them from malaria infection before their pregnancy, 
and might therefore reduce the prevalence of malaria in the first 
trimester of pregnancy, and its related poor maternal and birth 
outcomes. Such strategies may rely on highly sensitive diag-
nostic tests that help in the identification of women who need 
to be treated before pregnancy.
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